Diagnostic Failure

What happens when symptoms are dismissed, misread, or filed under the wrong framework entirely: and what that costs patients over time.

When Symptoms Don't Count as Evidence

A lot of my university coursework focused on immigrant and refugee populations. Specifically the linguistic barriers that determine community and health outcomes. Not just "does the interpreter show up" but the structural ways language access decides whether people can get access to supportive services, or if symptoms get investigated or dismissed.

That illustrated something: the gap between experiencing symptoms and having those symptoms treated as evidence isn't clinical. It's political.

Poor Historians

There's a term that shows up in medical charts. "Poor historian." Sounds neutral? It isn't.

Willie Ramirez was 18 when his family rushed him to a Florida hospital in 1980. Unconscious. His family told doctors he was "intoxicado": Spanish for adverse effects from anything ingested. Food poisoning, medication reaction, whatever. The hospital staff heard "intoxicated." Drugs. Alcohol. They treated him for overdose.

He had an intracerebral hemorrhage. Brain bleeding. Treatable if you catch it early.

By the time they figured it out, Willie Ramirez was quadriplegic. The settlement was $71 million.

That case is famous because it's extreme. The pattern isn't.

A study tracking pediatric encounters with Spanish interpreters found an average of 31 interpretation errors per appointment. Thirty-one. Per appointment. Sixty-three percent had potential clinical consequences. Omitting questions about drug allergies. Wrong dosing instructions for antibiotics. Telling a mother to put ear infection medication in both ears instead of explaining it's oral amoxicillin.

When professional interpreters made errors, 53% had clinical consequences. When ad hoc interpreters made errors: family members, nurses, an 11-year-old sibling doing medical interpretation for their parent: that jumped to 77%.

Here's where it gets structural. Doctors under time pressure decide whether using an interpreter is "worth it" for each interaction. They reserve interpreters for "important" conversations. Goals of care discussions. End of life planning. Routine symptom assessment? They skip it.

One medical student wrote about a patient who'd been seen by multiple physicians. All of them noted communication difficulties due to language barriers. All of them labeled him a "poor historian" in the chart. The student called for an interpreter anyway. Turns out the patient had been taking high doses of meloxicam post-surgery without understanding what it was. He had NSAID-induced nephritis and a bleeding gastric ulcer.

The student prevented a missed diagnosis. Maybe a delayed one. Because she didn't accept "poor historian" as the end of the investigation.

The term does something insidious. It suggests the problem is the patient's inability to give a clear account. Not the system's failure to provide interpretation. Not the physician's choice to skip the interpreter to save 15 minutes. The patient gets labeled deficient. The chart reflects that. It absolves the provider of responsibility for taking a complete history with a competent interpreter.

Sources

The Healthy Immigrant Paradox

There's a phenomenon in immigrant health research. Healthy immigrant paradox. Immigrants arrive with better health than native-born people of similar demographics. Then their health deteriorates. Sometimes converging to native-born outcomes. Sometimes worse.

Longitudinal data from Germany found immigrants showed faster individual-level declines in subjective and mental health than natives. Immigrant women experience faster health decline than immigrant men. Shift to poorer health at earlier ages. Recent Mexican migrants showed overall health decline within the first two years compared to non-migrants and earlier migrants.

Some of this is acculturation. Adopting less healthy behaviors. Dietary changes. But a significant piece is healthcare access.

Chinese and Punjabi-speaking individuals with limited English proficiency delay accessing healthcare until they find providers who speak their language. When they do access care, they're less likely to return if the experience was frustrating. One immigrant in a Canadian study said: "I cannot speak English well and so cannot explain what I need. I got so frustrated with the doctors; did not go to see one in one whole year but that came to harm me. I now have pain in my ankle which is growing but what is the use of telling the doctors; I cannot explain properly and they will not understand and it will not help."

That's not health anxiety. That's pattern recognition. That person learned their symptoms won't count as evidence unless they can articulate them in English. In a 15-minute appointment. To a provider who has already decided whether the interpreter is worth the time.

Sources

Gender

The language barrier data matters because it's one axis of a larger problem. Whose symptoms count as evidence depends on who's reporting them.

A study analyzing 200 million medical records found women experience significantly longer diagnostic delays than men even when presenting with similar symptoms. Not because diseases present differently in women: though that's also true: but because something about being a woman reporting symptoms triggers different clinical responses.

Women with moderate hemophilia get diagnosed 6.5 months later than men. Women with severe hemophilia: 39-month delay. Women with von Willebrand disease: 16-year delay between symptom onset and diagnosis.

There's no medical reason for this. Women are more likely to notice bleeding disorder symptoms because of menstruation.

For endometriosis, average time from first consultation to diagnosis is 4.4 years. Pain gets dismissed as psychological. For heart disease, women are less likely to experience "classic" symptoms; which really means male-pattern symptoms. Diagnostic criteria are geared toward males. Women's presentations get labeled "atypical."

With identical symptoms, a woman with chest tightness is three times more likely to be prescribed anxiolytics than a man. The man gets the cardiology referral.

Sixty-two percent of people with autoimmune diseases report being labeled "chronic complainers" by doctors or told they're "too concerned with health." Seventy-five percent of autoimmune patients are women.

There's a term for this. Yentl Syndrome. Coined by Dr. Bernadine Healy. For a woman's illness to be taken seriously, she must prove herself as unwell as a male counterpart.

Sources

Race

Black adults report being treated unfairly or judged by healthcare providers because of race at rates of 35%. That's not abstract. It shows up in pain management. Diagnostic accuracy. Symptom credibility.

Large database studies controlling for age, severity, insurance, and hospital type found Black patients significantly less likely than white patients to receive major therapeutic procedures in almost half of 77 disease categories. Even for low-discretion, clinically urgent procedures. Appendectomy. Abdominal aortic aneurysm repair.

For ALS, there's a large racial difference in diagnostic delay. Black patients have greater disease severity and lower respiratory function at the time of diagnosis. That prolongs access to disease-modifying therapies, multidisciplinary care, durable medical equipment, respiratory and nutritional support.

For multiple myeloma: one of the most common blood cancers, most frequently diagnosed among African Americans: patients see their primary doctor an average of three times before accurate diagnosis. The delay from symptom onset to diagnosis is even longer for Black Americans. One Black woman's endocrinologist recommended a hematology referral and bone marrow biopsy after finding high protein in her blood. Her primary care doctor refused both.

For multiple sclerosis, Black and Latinx patients have higher disability and increased symptom burden versus white patients at diagnosis. Many patients of color come to clinics on old medications that aren't working well. Reluctant to start more powerful disease-modifying therapies even with progressive disease. Not because they're noncompliant. Because they've learned to distrust the healthcare system.

Sources

Weight

Seventy-four percent of first-year medical students exhibit implicit weight bias. Sixty-seven percent exhibit explicit bias.

This shows up in clinical encounters as attribution bias. Physicians attribute health conditions to a patient's weight because it's low-hanging fruit. Recommend lifestyle changes rather than investigation.

Patients with higher BMI get told to lose weight before any further testing will be done. This causes considerable delays in diagnosis and treatment of serious conditions.

For eating disorders in higher-BMI patients, diagnosis gets delayed an average of nine months compared to patients who were never overweight. When patients from these populations are perceived as losing weight: even rapidly: physicians are less inclined to ensure healthy weight loss or rule out disordered eating. If the patient is fat, clinicians investigate binging behaviors rather than questioning caloric restriction or compulsive exercise.

Nearly 70% of people who are overweight report feeling stigmatized by physicians. Women in particular delay seeking healthcare to avoid shame or because they fear the physician will attribute all health concerns solely to weight. They let things "exacerbate to a huge degree" before seeking medical care.

Obese women are less likely to be up to date on breast exams and pap smears. Often due to embarrassment. Perceived weight stigma during visits. Lack of appropriately sized equipment. Poor patient-provider communication. This leads to delayed cancer diagnoses. Increased morbidity and mortality.

Sources

My Favorite: Medically Unexplained Symptoms

Fifteen to thirty percent of primary care visits result in symptoms labeled "medically unexplained." The term sounds neutral. It isn't.

MUS is what gets written in the chart when symptoms don't fit textbook presentations. When they span multiple systems. When they're subjective: pain, fatigue, dizziness: without objective findings on standard tests. The label treats lack of explanation as the endpoint rather than a prompt for further investigation.

It can take five or more years to get a diagnosis after symptoms are labeled medically unexplained. During that time, the conceptualization of MUS as somatization supports linear explanations where psychological problems get framed as "the cause."

Only one-third of patients with MUS meet criteria for depression or generalized anxiety disorder. But the chart says MUS and the patient gets referred to psychiatry while the underlying condition progresses.

The body-mind duality imposed by the biomedical model means illness gets categorized as psychological when no objective findings are identified. That's not the same as saying the illness is psychological. It's saying we haven't looked hard enough yet. Or we're not looking in the right places. Or the diagnostic criteria were designed for a different population and this patient doesn't fit the mold.

Sources

What This Means

Pattern recognition trained on narrow populations fails diverse patients. Diagnostic criteria based on male, white, thin presentations mean "atypical" becomes code for "your symptoms don't count."

This isn't about individual doctors being bad at their jobs.

Most physicians would say it's unfair for certain groups to receive worse care.

But implicit bias plus structural factors: time constraints in 15-minute appointments, fragmented care across specialties, insurance gatekeeping of diagnostic tests, medical education based on the male and white and thin model: produces predictable disparities.

The consequences aren't abstract. Delayed treatment means worse outcomes. Higher morbidity. Increased mortality. Healthcare avoidance due to previous dismissal. Erosion of trust in the medical system. Patients labeled "difficult," "treatment-resistant," "chronic complainers." Economic costs from more appointments, more ER visits, lost work time.

Getting to the point of treatment requires privileges. Being believed is unfortunately a privilege. So is having symptoms recognized as legitimate, and matching the population diagnostic criteria were designed for.

My earlier posting about compliance showed how clinical frameworks assume privileges patients don't have. Stable housing. Reliable transportation. Ability to take time off work.

This is the step before that. This is about whether your symptoms count as evidence in the first place.

When someone says "I've been to five doctors and nobody will listen," that's not health anxiety. That's accurate pattern recognition. They've learned the system doesn't treat their symptoms as credible.

The question isn't whether the patient is a poor historian. The question is whether the system is designed to hear them at all.

(This was a post that could definitely get fleshed out quicker thanks to links, books and the leftovers of my old academic life, so we'll see how things pan out in the future!)

When Pattern Recognition Gets Called Anxiety

This post is late thanks to having my routine, yearly reaction to radiators blasting: a lil upper respiratory adventure, but this year included fevers. But no body aches and flu-like fever, just elevated body temperature off and on for a couple of days and some clear, flowing snot. Nothing to worry about until my left foot (aka, my Good Side/Foot) started curling and getting a weird weakness in the metatarsal area. I overthought that for a few days, seeing it ebb and flow with the general level of how bad I felt.

Importantly: I didn't run to my neurologist immediately with "Hey this is like what happened when my right foot started dropping spring 2024" because in my history most of my coming to doctors gets shot down immediately. Like an ER visit for a mold exposure respiratory issue in 2017 which included what are retrospectively MS flare symptoms (urinary incontinence, falling down constantly, muscle weakness, right side facial numbness); which were a point to be mocked and joked about by one especially rancid ER nurse until the x-rays came back. That ER had been abusive before. I went there anyway, desperately seeking antibiotics I couldn't get off Amazon after being sick with bronchitis for just over a month.

When you're not just broke but actually poor you stay in tune with your systems and DIY out of financial necessity.

As a former powerlifter I am aware of my physicality. I know how the systems interplay and generally function. But as an autistic person who lives in data and verifying reality through reading... Yeah I started digging around and I found one shred of freely accessible research about people like me that rubbed me wrong because so much context was smoothed away:

Galvin, J., & Richards, G. (2023). Health anxiety in autistic adults. Research in Autism Spectrum Disorders, 102, Article 102146.

This 2023 UK study measured health anxiety in autistic adults. About one in three autistic participants reported clinically significant levels of health anxiety, compared to 8.8% of non-autistic participants. The authors found that autistic traits positively correlated with health anxiety and concluded that characteristics like "restricted attention, hyper-attention to detail, repetitive behaviours and sensory hypersensitivity" could lead to "elevated vigilance towards bodily sensations, greater checking of the body, more misinterpretation of symptoms."

The study is methodologically sound for what it measured. But it didn't measure the obvious confound: whether the health anxiety was accurate.

The Missing Variable

The researchers recruited 110 autistic adults and 110 non-autistic adults. They measured autistic traits using the Autism Spectrum Quotient. They measured health anxiety using the Short Health Anxiety Inventory. They controlled for generalized anxiety, depression, age, and sex.

They didn't measure participants' actual health histories. They didn't track whether participants with high health anxiety scores subsequently got diagnosed with health conditions. They didn't examine whether autistic participants' vigilance about bodily sensations correlated with actual undiagnosed problems.

This matters because autistic adults have documented higher rates of co-occurring health conditions: autoimmune diseases, connective tissue disorders, GI problems, autonomic dysfunction. Autistic adults also experience longer diagnostic delays and higher rates of symptom dismissal.

When you're statistically more likely to have undiagnosed health conditions AND more likely to have symptoms dismissed, increased vigilance about your body isn't necessarily pathological. It might be accurate risk assessment.

The study acknowledged this in the limitations: "The higher rates of health anxiety reported by the autistic sample might reflect, to some extent at least, an actual increased rate of comorbid health issues within this group."

But they treated this as a limitation rather than as a variable that needed measurement.

How the Instrument Works

The Short Health Anxiety Inventory includes items like "I spend most of my time worrying about my health" and "I usually feel at high risk for developing a serious illness." Higher scores indicate clinically significant health anxiety.

The inventory assumes worry is disproportionate to actual risk. That assumption works for populations where health anxiety rarely corresponds to actual illness. It's less clear it works for populations with genuinely elevated health risks and documented patterns of medical dismissal.

If you're part of a population where unexplained symptoms frequently turn out to be real problems, and where those problems are often dismissed initially, then persistent concern about your health isn't necessarily anxiety. It might be pattern recognition based on prior experience.

The study doesn't distinguish between these possibilities.

The Framing Problem

Every autistic trait in the paper gets interpreted through a deficit lens. Restricted attention becomes "can't stop focusing on symptoms." Hyper-attention to detail becomes "notices too many body sensations." Sensory hypersensitivity becomes "feels normal sensations too intensely."

But these same traits could be framed as competencies. Restricted attention enables sustained focus on symptom patterns over time. Hyper-attention to detail means noticing subtle physiological changes. Sensory hypersensitivity might enable early detection of problems.

Whether these traits represent dysfunction or capability depends on whether the concern about bodily sensations is accurate. The study assumes it's not without testing that assumption.

What This Enables Clinically

The authors recommend that clinicians "may wish to consider autistic traits in the early stages of assessment and treatment planning for patients...experiencing health anxiety/hypochondria."

This is reasonable clinical advice if health anxiety in autistic patients is primarily pathological worry.

It becomes problematic if health anxiety in autistic patients frequently corresponds to actual undiagnosed conditions. Then flagging autistic patients as having higher rates of health anxiety disorder could justify attributing their symptoms to anxiety rather than investigating thoroughly.

The study doesn't provide evidence to distinguish between these scenarios.

What Different Methodology Would Look Like

Research that actually tested whether health anxiety in autistic adults is pathological or adaptive would need to measure whether high health anxiety scores predict future health diagnoses.

You'd recruit autistic adults with varying levels of health anxiety. You'd document their current health concerns. You'd follow up at intervals to track which participants received new diagnoses. You'd examine whether baseline health anxiety scores correlated with subsequent diagnosis of actual health conditions.

If high health anxiety scores predicted later diagnosis of real problems, that would suggest the anxiety was warranted. If they didn't, that would support the pathological interpretation.

The current study doesn't do this. It measures a phenomenon: autistic adults report more health anxiety: and interprets it as pathology without testing whether that interpretation is correct.

Why the Framing Matters

Research gets cited. This study will influence how clinicians think about autistic patients who report persistent physical symptoms.

A clinician who reads this study learns that autistic patients are more likely to experience health anxiety and misinterpret normal bodily sensations. When an autistic patient reports symptoms, the clinician might be primed to consider health anxiety as an explanation.

That's appropriate if the health anxiety is primarily pathological. It's inappropriate if autistic patients' increased vigilance corresponds to increased actual health problems that are systematically underdiagnosed.

The study doesn't give clinicians information to distinguish between these cases. It just tells them autistic patients have more health anxiety and frames that anxiety through a deficit lens.

The Pattern the Study Actually Documents

The study shows autistic adults are more vigilant about their health than non-autistic adults. That's not in question.

What's not established: whether this vigilance is disproportionate to actual risk, whether it represents misinterpretation of normal sensations, or whether it's an adaptive response to genuinely elevated health risks combined with systematic medical dismissal.

The researchers interpret their findings through one framework: autistic traits exacerbate pathological health anxiety: without ruling out the alternative framework: autistic traits enable accurate detection of actual health problems in a population with higher rates of those problems.

Both interpretations fit the data they collected. They only tested one.

That's not bad research. It's incomplete research that gets presented as if the question is settled.

(Now I am going to go back to autistically monitoring my mucus colors because I don't have employer health insurance. Here's to hoping next week my posting will be on schedule.)

Why This Isn't Just About MS: The Diagnostic Delays Nobody Talks About

Let me tell you something that aggravates me: when people hear "28 years of symptoms before diagnosis," they think it's unusual. That I'm some statistical outlier, a medical mystery, a rare case study.

I'm really not.

I'm actually normal-ish.

Here's what the research actually shows about autoimmune disease diagnosis in the US:

Rheumatoid Arthritis: Clinical standard says weeks to 3 months. Patient reality? 1-2 years. Why? Because early joint pain gets dismissed as aging, injury, or "just stress" until you can finally see a rheumatologist: assuming you can get the referral and afford the wait.

Lupus: Should take 6 months to a year. Actually takes over 4 years on average; the Lupus Foundation found many patients waited 6+ years. Lupus is called "the great imitator" because symptoms fluctuate and span multiple systems, so doctors treat you like a hypochondriac making things up.

Celiac Disease: The test is straightforward. Takes weeks if anyone bothers to order it. Patient reality? 6-10 years. A decade of being told you have IBS, that you're stressed, that you need therapy, before someone finally checks if gluten is literally destroying your intestines.

Inflammatory Bowel Disease (Crohn's/UC): Clinical standard is 3-9 months. Patient experience? 1-5 years of being misdiagnosed with appendicitis, infections, IBS, or "nervous stomach" before someone does the colonoscopy that shows your bowel is inflamed as hell.

Multiple Sclerosis: Should be diagnosed within months to a year using the McDonald Criteria. Median patient reality? 4 years. My 28 years of symptoms puts me at the far end, but plenty of people spend a decade or more being told their neurological symptoms are migraines, stress, or psychiatric problems.

Sources

So What's Happening Here?

The clinical standards assume material conditions that are decreasingly present for Americans: you can afford specialists, you can take time off work for multiple appointments, your symptoms show up on a good day when you're being examined, your doctor believes you, your insurance approves the tests, someone thinks to order the right test in the first place.

Patient reality accounts for non-specific symptoms that doctors dismiss; no single definitive test for most autoimmune diseases; specialist shortages and months-long wait times; symptoms that fluctuate and disappear during appointments; medical dismissiveness, especially for women, people of color, fat people, poor people; and the fact that "diagnostic odyssey" is such a common experience they gave it a name.

This is systemic failure, not patient failure.

When I write about MS, I'm writing about a system that took 28 years to believe my symptoms were real. But I'm also writing for everyone with Hashimoto's who was told they were just lazy and/or depressed. For everyone with celiac who spent a decade on antidepressants while gluten destroyed their gut. For everyone with lupus who was called a hypochondriac while their organs were under attack.

The research that excludes us, the compliance myths that blame us, the gap between clinical protocols and material reality: this is everyone's fight.

That's why this writing exists. Not just for MS patients. For everyone the system failed while pretending the standards were working just fine.